Get the Stockscreener App
2.21
0.91%
0.02
Aytu Biopharma Inc stock is traded at $2.21, with a volume of 65,139.
It is up +0.91% in the last 24 hours and up +1.84% over the past month.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
See More
Previous Close:
$2.19
Open:
$2.19
24h Volume:
65,139
Relative Volume:
0.05
Market Cap:
$19.84M
Revenue:
$93.76M
Net Income/Loss:
$-13.68M
P/E Ratio:
-0.8403
EPS:
-2.63
Net Cash Flow:
$8.77M
1W Performance:
-6.75%
1M Performance:
+1.84%
6M Performance:
+59.57%
1Y Performance:
-14.87%
1-Day Range:
$2.18
$2.24
1-Week Range:
$2.15
$2.3458
52-Week Range:
$0.95
$2.85
Aytu Biopharma Inc Stock (AYTU) Company Profile
Name
Aytu Biopharma Inc
Sector
Phone
(720) 437-6580
Address
7900 E. UNION AVENUE, DENVER
Compare AYTU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.21 | 19.66M | 93.76M | -13.68M | 8.77M | -2.63 |
|
ZTS
Zoetis Inc
|
154.11 | 67.83B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.00 | 46.74B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.52B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.86 | 20.12B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
313.13 | 14.11B | 2.99B | 1.21B | 1.13B | 25.06 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Initiated | Lake Street | Buy |
| Jun-30-25 | Initiated | Ascendiant Capital Markets | Buy |
| Mar-30-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-29-20 | Initiated | H.C. Wainwright | Buy |
Aytu Biopharma Inc Stock (AYTU) Latest News
Will Aytu BioPharma Inc. stock recover after recent dropPortfolio Value Summary & Consistent Income Trade Recommendations - Newser
Live market analysis of Aytu BioPharma Inc.July 2025 Action & AI Enhanced Trading Signals - Newser
Using Python tools to backtest Aytu BioPharma Inc. strategiesEarnings Recap Summary & Smart Money Movement Alerts - Newser
Will Aytu BioPharma Inc. outperform the marketJuly 2025 Catalysts & AI Forecast for Swing Trade Picks - Newser
What recovery options are there for Aytu BioPharma Inc.July 2025 Short Interest & Risk Controlled Daily Plans - Newser
Will Aytu BioPharma Inc. see short term momentumJuly 2025 Weekly Recap & Low Risk Investment Opportunities - Newser
What machine learning models say about Aytu BioPharma Inc.2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Can trapped investors hope for a rebound in Aytu BioPharma Inc.Quarterly Portfolio Summary & Target Return Focused Picks - Newser
Aytu BioPharma Inc. stock daily chart insightsWeekly Investment Summary & Free High Accuracy Swing Entry Alerts - Newser
Why Aytu BioPharma Inc. stock attracts strong analyst attentionTrade Analysis Report & Fast Moving Stock Trade Plans - Newser
How hedge fund analytics apply to Aytu BioPharma Inc. stockPortfolio Risk Report & Reliable Price Action Trade Plans - Newser
Multi asset correlation models including Aytu BioPharma Inc.Rate Cut & Low Risk Investment Opportunities - Newser
Full technical analysis of Aytu BioPharma Inc. stockMarket Growth Review & Pattern Based Trade Signal System - Newser
Can Aytu BioPharma Inc. benefit from deglobalizationFast ROI Stock Opportunities - thegnnews.com
Combining price and volume data for Aytu BioPharma Inc.Free Weekly Watchlist of High Movers - Newser
How to recover losses in Aytu BioPharma Inc. stockDaily Technical Forecast for Quick Gains - Newser
Risk adjusted return profile for Aytu BioPharma Inc. analyzedFundamental Analysis for Value Stock Selection - Newser
What the charts say about Aytu BioPharma Inc. todayFree Access to Real-Time Trade Insights - Newser
Aytu BioPharma Inc. stock retracement – recovery analysisMarket Opportunity Tracker for Swing Traders - Newser
What makes Aytu BioPharma Inc. stock price move sharplyCapitalize on market shifts with expert advice - Jammu Links News
What are the latest earnings results for Aytu BioPharma Inc.Exceptional trading results - Jammu Links News
What are analysts’ price targets for Aytu BioPharma Inc. in the next 12 monthsInvest smarter with advanced market data - Jammu Links News
How does Aytu BioPharma Inc. compare to its industry peersGet real-time alerts on high-potential stocks - Jammu Links News
Does Aytu BioPharma Inc. stock perform well during market downturnsCapitalize on high-growth stocks early - Jammu Links News
Should I hold or sell Aytu BioPharma Inc. stock in 2025Capitalize on momentum-driven investment opportunities - Jammu Links News
Is it the right time to buy Aytu BioPharma Inc. stockInvest confidently with real-time data - Jammu Links News
What are Aytu BioPharma Inc. company’s key revenue driversSuperior investment outcomes - Jammu Links News
Aytu Biopharma Inc Stock (AYTU) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aytu Biopharma Inc Stock (AYTU) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Disbrow Joshua R. | Chief Executive Officer |
Jun 09 '25 |
Buy |
1.50 |
66,666 |
99,999 |
153,257 |
| Disbrow Joshua R. | Chief Executive Officer |
Feb 28 '25 |
Buy |
1.30 |
15,000 |
19,500 |
86,591 |
2.80%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):